Evidence map›Paper›PMID 39485730›Full record

Trial reportHealth technology assessment (Winchester, England)2024

Comparison of cognitive behaviour therapy versus activity management, both delivered remotely, to treat paediatric chronic fatigue syndrome/myalgic encephalomyelitis: the UK FITNET-NHS RCT.

Esther Crawley, Emma Anderson, Madeleine Cochrane, Beverly A Shirkey, Roxanne Parslow, William Hollingworth, Nicola Mills, Daisy Gaunt, Georgia Treneman-Evans, Manmita Rai and 12 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Health technology assessment (Winchester, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Esther CrawleyCentre for Academic Child Health, Bristol Medical School: Population Health Sciences, University of Bristol, Bristol, UK.ORCID 0000-0002-2521-0747
Emma AndersonCentre for Academic Child Health, Bristol Medical School: Population Health Sciences, University of Bristol, Bristol, UK.ORCID 0000-0002-4639-9067
Madeleine CochraneBristol Trials Centre, University of Bristol, Bristol, UK.ORCID 0000-0003-1856-3293
Beverly A ShirkeyBristol Trials Centre, University of Bristol, Bristol, UK.ORCID 0000-0002-4347-6784
Roxanne ParslowCentre for Academic Child Health, Bristol Medical School: Population Health Sciences, University of Bristol, Bristol, UK.ORCID 0000-0002-3612-7121
William HollingworthBristol Medical School: Population Health Sciences, University of Bristol, Bristol, UK.ORCID 0000-0002-0840-6254
Nicola MillsBristol Medical School: Population Health Sciences, University of Bristol, Bristol, UK.ORCID 0000-0002-2960-2940
Daisy GauntBristol Trials Centre, University of Bristol, Bristol, UK.ORCID 0000-0002-1253-307X
Georgia Treneman-EvansCentre for Academic Child Health, Bristol Medical School: Population Health Sciences, University of Bristol, Bristol, UK.ORCID 0000-0003-0707-6078
Manmita RaiKing's College London, London, UK.ORCID 0000-0001-6232-2716
John MacleodBristol Medical School: Population Health Sciences, University of Bristol, Bristol, UK.ORCID 0000-0001-8202-1144
David KesslerBristol Medical School: Population Health Sciences, University of Bristol, Bristol, UK.ORCID 0000-0001-5333-132X
Kieren PittsResearch IT, University of Bristol, Bristol, UK.ORCID 0000-0002-0927-7677
Serena CooperResearch IT, University of Bristol, Bristol, UK.ORCID 0000-0003-4948-6235
Maria LoadesCentre for Academic Child Health, Bristol Medical School: Population Health Sciences, University of Bristol, Bristol, UK.ORCID 0000-0002-0839-3190
Ammar AnnawBristol Trials Centre, University of Bristol, Bristol, UK.ORCID 0000-0001-7626-7519
Paul StallardDepartment for Health, University of Bath, Bath, UK.ORCID 0000-0001-8046-0784
Hans KnoopDepartment of Medical Psychology, Amsterdam University Medical Centres, Amsterdam Public Health Research Institute, University of Amsterdam, Amsterdam, Netherlands.ORCID 0000-0001-7763-3517
Elise Van de PutteDepartment of Paediatrics, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, Netherlands.ORCID 0000-0001-7232-3827
Sanne NijhofDepartment of Paediatrics, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, Netherlands.ORCID 0000-0003-1538-5014
Gijs BleijenbergRadboud University Medical Center, Nijmegen, Netherlands.ORCID 0000-0002-3822-1162
Chris MetcalfeBristol Trials Centre, University of Bristol, Bristol, UK.ORCID 0000-0001-8318-8907

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Design: Parallel-group randomised controlled trial. Methods: Adolescents aged 11-17 years, diagnosed with myalgic encephalomyelitis/chronic fatigue syndrome and with no local specialist treatment centre, were referred to a specialist service in South West England. Interventions: Fatigue In Teenagers on the interNET in the National Health Service is a web-based myalgic encephalomyelitis/chronic fatigue syndrome-focused cognitive-behavioural therapy programme for adolescents, supported by individualised written, asynchronous electronic consultations with a clinical psychologist/cognitive-behavioural therapy practitioner. The comparator was videocall-delivered activity management with a myalgic encephalomyelitis/chronic fatigue syndrome clinician. Both treatments were intended to last 6 months. Objectives: Estimate the effectiveness of Fatigue In Teenagers on the interNET in the National Health Service compared to Activity Management for paediatric myalgic encephalomyelitis/chronic fatigue syndrome. Estimate the effectiveness of Fatigue In Teenagers on the interNET in the National Health Service compared to Activity Management for those with mild/moderate comorbid mood disorders. From a National Health Service perspective, estimate the cost-effectiveness of Fatigue In Teenagers on the interNET in the National Health Service compared to Activity Management over a 12-month horizon. Primary Outcome: 36-item Short Form Health Survey Physical Function subscale at 6 months post randomisation. Randomisation: Web-based, using minimisation with a random component to balance allocated groups by age and gender. Blinding: While the investigators were blinded to group assignment, this was not possible for participants, parents/carers and therapists. Results: The treatment of 314 adolescents was randomly allocated, 155 to Fatigue In Teenagers on the interNET in the National Health Service. Mean age was 14 years old and 63% were female. Primary outcome: At 6 months, participants allocated to Fatigue In Teenagers on the interNET in the National Health Service were more likely to have improved physical function (mean 60.5, standard deviation 29.5, Secondary outcomes: Fatigue In Teenagers on the interNET in the National Health Service participants attended, on average, half a day more school per week at 6 months than those allocated Activity Management, and this difference was maintained at 12 months. There was no strong evidence that comorbid mood disorder impacted upon the relative effectiveness of the two interventions. Similar improvement was seen in the two groups for pain and the Clinical Global Impression scale, with a mixed picture for fatigue. Both groups continued to improve, and no clear difference in physical function remained at 12 months [difference in means 4.4 (95% confidence interval -1.7 to 10.5)]. One or more of the pre-defined measures of a worsening condition in participants during treatment, combining therapist and patient reports, were met by 39 (25%) participants in the Fatigue In Teenagers on the interNET in the National Health Service group and 42 (26%) participants in the Activity Management group. A small gain was observed for the Fatigue In Teenagers on the interNET in the National Health Service group compared to Activity Management in quality-adjusted life-years (0.002, 95% confidence interval -0.041 to 0.045). From an National Health Service perspective, the costs were £1047.51 greater in the Fatigue In Teenagers on the interNET in the National Health Service group (95% confidence interval £624.61 to £1470.41). At a base cost-effectiveness threshold of £20,000 per quality-adjusted life-year, the incremental cost-effectiveness ratio was £457,721 with incremental net benefit of -£1001 (95% confidence interval -£2041 to £38). Conclusion: At 6 months post randomisation, compared with Activity Management, Fatigue In Teenagers on the interNET in the National Health Service improved physical function and school attendance. The additional cost of Fatigue In Teenagers on the interNET in the National Health Service and limited sustained impact mean it is unlikely to be cost-effective. Trial registration: This trial is registered as ISRCTN18020851. Funding: This award was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme (NIHR award ref: 14/192/109) and is published in full in

Indexed as

Cognitive Behavioral TherapyCost-Benefit AnalysisFatigue Syndrome, ChronicState MedicineAdolescentChildFemaleHumansInternetMaleQuality-Adjusted Life YearsQuality of LifeUnited KingdomADOLESCENTCAREGIVERSCHILDCHRONIC FATIGUE SYNDROMECOGNITIVE BEHAVIORAL THERAPYE-COUNSELLINGEHEALTHE-THERAPYMYALGIC ENCEPHALOMYELITISONLINE SYSTEMSPARENTSPEDIATRICSPILOT PROJECTSPRAGMATIC CLINICAL TRIALQUALITATIVE RESEARCHRANDOMIZED CONTROLLED TRIALYOUNG PERSON

Identifiers

PMID39485730
PMCPMC11590115

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.